Most peptides will never be a pill, and knowing which ones can be saves years.
A good decision layer turns a risky guess into a documented, reviewable call. This guide is a practical, research-use walkthrough, written for people who have to make a real call about a real sequence.
Most peptides will never be a pill, and knowing which ones can be saves years. EndoPhase exists to put that judgement at the start of the process, where it is cheapest, and to keep the reasoning on record.
Most wasted peptide budget is decided at the sequence stage, long before the lab gets involved. The teams that do this well are not the ones with the biggest models. They are the ones who decide what is worth making before they make it, and who write down why.
Reality gets captured, so the next decision starts smarter than the last. That is the whole job: a decision layer between an idea and a synthesis order.
Request beta accessEndoPhase is research-use software. It does not sell peptides, give medical advice, diagnose, treat, or make claims about the safety or efficacy of any compound named here. Names are used as analysis subjects only.